/
Reference to a year (e.g., 2025 ) refers to our fiscal year ended March 31 of that year. We formed as a Delaware corporation in 1996 and are engaged in the development, manufacturing, marketing, sales and distribution of well-recognized, brand name, over-the-counter ( OTC ) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club stores and e-commerce chann…
28.69% operating margin is above average. ROIC at 8.34%. Note that capital returns lag the margin, the business may be capital-intensive despite high margins.
Revenue declined 5.2% YoY. The question is whether this is cyclical or a structural shift.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$1.08B
▼ -5.2% YoY
Net Income (TTM)
$190M
▼ -11.3% YoY
Op. Margin
28.69%
▼ -0.9pp YoY
ROIC
8.34%
▼ -1.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$246M
▲ +1.3% YoY
Op. Cash Flow (TTM)
$258M
▲ +2.4% YoY
Net Debt
$979M
Cash & Equiv.
$64M
5Y CAGR: +2.7%
5Y CAGR: +2.9%
Continue Research